Bengt Robertson

Q: What Schools Are Affiliated With Bengt Robertson

Bengt Robertson is affiliated with the following schools: Kanazawa University, Karolinska Institute

Bengt Robertson's AcademicInfluence.com Rankings

Bengt Robertson

Literature

#4586

World Rank

#7270

Historical Rank

literature Degrees

Download Badge

Literature

Why Is Bengt Robertson Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Bengt A. Robertson was a Swedish physician. Robertson was primarily known for the development of the synthetic lung surfactant known as Corusurf. In 1996 he was awarded the King Faisal International Prize in Medicine together with Tetsurō Fujiwara for contributions to the understanding of neonatal medicine.

(See a Problem?)

Bengt Robertson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

In Vivo Lung Lavage as an Experimental Model of the Respiratory Distress Syndrome (1980) (627)
Manual Ventilation with a Few Large Breaths at Birth Compromises the Therapeutic Effect of Subsequent Surfactant Replacement in Immature Lambs (1997) (555)
Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. (1994) (440)
Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. (1999) (408)
Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity. (1987) (282)
Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. (1972) (278)
The pulmonary surfactant system: biochemical aspects and functional significance. (1988) (271)
Pulmonary Surfactant: From Molecular Biology to Clinical Practice (1992) (249)
The proteins of the surfactant system. (1994) (227)
Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. (1997) (210)
Hydrophobic surfactant-associated polypeptides: SP-C is a lipopeptide with two palmitoylated cysteine residues, whereas SP-B lacks covalently linked fatty acyl groups. (1990) (196)
Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. (1992) (194)
Modes of artificial ventilation in severe respiratory distress syndrome. Lung function and morphology in rabbits after wash‐out of alveolar surfactant (1982) (189)
Surfactant inhibition in experimental meconium aspiration (1993) (168)
Lung Surfactant and the Pathogenesis of Neonatal Bronchiolar Lesions Induced by Artificial Ventilation (1978) (164)
Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. (1994) (159)
Pilot study of nebulized surfactant therapy for neonatal respiratory distress syndrome (2000) (153)
Principles of surfactant replacement. (1998) (149)
Surfactant Treatment of Neonates With Respiratory Failure and Group B Streptococcal Infection (2000) (143)
Inactivation of Exogenous Surfactant by Pulmonary Edema Fluid (1991) (116)
Surface activity of lipid extract surfactant in relation to film area compression and collapse. (1994) (109)
Isoxsuprine-induced release of pulmonary surfactant in the rabbit fetus. (1977) (101)
Phagocytic Functions and Tumor Necrosis Factor Secretion of Human Monocytes Exposed to Natural Porcine Surfactant (Curosurf) (1991) (100)
Low-molecular-mass surfactant protein type 1. The primary structure of a hydrophobic 8-kDa polypeptide with eight half-cystine residues. (1988) (100)
Experimental Neonatal Respiratory Failure Induced by a Monoclonal Antibody to the Hydrophobic Surfactant-Associated Protein SP-B (1991) (96)
Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C. (1995) (91)
Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution. (1998) (89)
Resistance of Different Surfactant Preparations to Inactivation by Meconium (2001) (89)
Structural and Functional Characterization of Porcine Surfactant Isolated by Liquid-Gel Chromatography1 (1990) (88)
Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage (1986) (85)
Surfactant improves lung function and morphology in newborn rabbits with meconium aspiration. (1993) (81)
BRONCHIOLAR EPITHELIAL LESIONS INDUCED IN THE PREMATURE RABBIT NEONATE BY SHORT PERIODS OF ARTIFICIAL VENTILATION (1980) (77)
Comparison of prophylaxis and rescue treatment with Curosurf in neonates less than 30 weeks' gestation: a randomized trial. (1993) (77)
Incomplete protection by prophylactic surfactant against the adverse effects of large lung inflations at birth in immature lambs (2004) (76)
The adult respiratory distress syndrome: first trials with surfactant replacement. (1989) (76)
Size and structure of the hydrophobic low molecular weight surfactant-associated polypeptide. (1988) (71)
Polymer-surfactant treatment of meconium-induced acute lung injury. (2000) (71)
Surfactant therapy for lung disease (1995) (67)
Severe Neonatal Respiratory Distress Syndrome Treated with the Isolated Phospholipid Fraction of Natural Surfactant (1987) (66)
Tracheal deposition of surfactant before the first breath. (1973) (66)
Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration. (1994) (63)
A synthetic surfactant based on a poly-Leu SP-C analog and phospholipids: effects on tidal volumes and lung gas volumes in ventilated immature newborn rabbits. (2003) (63)
Improved ventilation of prematurely delivered primates following tracheal deposition of surfactant. (1978) (62)
Experimental obstructive hydronephrosis in newborn rats. I. Surgical technique and long-term morphologic effects. (1980) (61)
Experimental Neonatal Group B Streptococcal Pneumonia: Effect of a Modified Porcine Surfactant on Bacterial Proliferation in Ventilated Near-Term Rabbits (1994) (60)
Experimental evaluation of surfactants for replacement therapy. (1988) (59)
Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study. (1990) (58)
Leakage of protein in the immature rabbit lung; effect of surfactant replacement. (1985) (58)
Liquid ventilation in immature newborn rabbits. (1976) (58)
Hydrophobic 3.7 kDa surfactant polypeptide: Structural characterization of the human and bovine forms (1988) (58)
Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. (1998) (58)
Pathogenesis of neonatal lung lesions induced by artificial ventilation: evidence against the role of barotrauma. (1980) (57)
Spontaneous Breathing or Mechanical Ventilation Alters Lung Compliance and Tissue Association of Exogenous Surfactant in Preterm Newborn Rabbits (2005) (57)
Lung morphology and phospholipids after experimental inhalation of soluble cadmium, copper, and cobalt. (1984) (56)
Exogenous surfactant improves ventilation efficiency and alveolar expansion in rats with meconium aspiration. (1996) (56)
Artificial surfactant and natural surfactant. Comparative study of the effects on premature rabbit lungs. (1980) (56)
Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome. (2008) (55)
Healthy lungs tolerate repetitive collapse and reopening during short periods of mechanical ventilation (1995) (55)
Activity of pulmonary surfactant after blocking the associated proteins SP-A and SP-B. (1991) (55)
Pharyngeal deposition of surfactant in the premature rabbit fetus. (1973) (54)
Synthetic Surfactant Based on Analogues of SP-B and SP-C Is Superior to Single-Peptide Surfactants in Ventilated Premature Rabbits (2010) (54)
Lung recruitment at birth does not improve lung function in immature lambs receiving surfactant (2001) (54)
The Pulmonary Surfactant System (1994) (53)
Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome (2002) (51)
Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial (1996) (51)
Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A. (1997) (51)
Lung-Thorax Compliance in the Artificially Ventilated Premature Rabbit Neonate in Relation to Variations in Inspiration: Expiration Ratio (1981) (51)
Lung mechanics during spontaneous ventilation in premature and fullterm rabbit neonates. (1979) (51)
The critical concentration of surfactant in fetal lung liquid at birth. (1990) (50)
Dextran reduces surfactant inhibition by meconium (2000) (49)
Surfactant Substitution in Ventilated Very Low Birth Weight Infants: Factors Related to Response Types (1991) (48)
Radiologic Observations in Severe Neonatal Respiratory Distress Syndrome Treated with the Isolated Phospholipid Fraction of Natural Surfactant (1987) (47)
Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. (2001) (47)
Physiological activity of pulmonary surfactant with low protein content: effect of enrichment with synthetic phospholipids. (1985) (46)
Influence of Modified Natural or Synthetic Surfactant Preparations on Growth of Bacteria Causing Infections in the Neonatal Period (2000) (45)
Canine hydrophobic surfactant polypeptide SP‐C A lipopeptide with one thioester‐linked palmitoyl group (1991) (45)
Synthetic surfactants to treat neonatal lung disease. (2000) (44)
Experimental partial ureteric obstruction in newborn rats. IV. Do the morphological effects progress continuously? (1983) (43)
Surfactant improves lung function and mitigates bacterial growth in immature ventilated rabbits with experimentally induced neonatal group B streptococcal pneumonia (1997) (43)
Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome. (1988) (42)
Treatment of severe meconium aspiration syndrome with porcine surfactant (1996) (42)
Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia. (1999) (42)
ARTIFICIAL VENTILATION OF PREMATURE NEWBORN RABBITS; EFFECTS OF POSITIVE END‐EXPIRATORY PRESSURE ON LUNG MECHANICS AND LUNG MORPHOLOGY (1980) (41)
Effects of long-term nickel dust exposure on rabbit alveolar epithelium. (1981) (40)
Application of a new ventilator-multi-plethysmograph system for testing efficacy of surfactant replacement in newborn rabbits. (1991) (40)
Rabbit lung after inhalation of hexa- and trivalent chromium. (1986) (40)
Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits. (1994) (38)
The alveolar lining of the premature newborn rabbit after pharyngeal deposition of surfactant. (1974) (38)
Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? (2000) (38)
Radiologic evaluation of the premature newborn rabbit after pharyngeal deposition of surfactant. (1975) (37)
Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. (1996) (37)
Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B. (1999) (37)
Inactivation of exogenous surfactant in experimental respiratory failure induced by hyperoxia (1988) (36)
Rabbit lung after inhalation of soluble nickel. II. Effects on lung tissue and phospholipids. (1983) (35)
Experimental partial ureteric obstruction in newborn rats. VII. Are the long term effects on renal morphology avoided by release of the obstruction? (1986) (35)
Very low surfactant protein C contents in newborn Belgian White and Blue calves with respiratory distress syndrome. (2000) (35)
[Lung function in premature infants can be improved. Surfactant therapy and CPAP reduce the need of respiratory support]. (1999) (35)
Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome (1993) (34)
Surfactant treatment in experimental Escherichia coli pneumonia (1996) (33)
Polymyxin B/Pulmonary Surfactant Mixtures Have Increased Resistance to Inactivation by Meconium and Reduce Growth of Gram-Negative Bacteria In Vitro (2006) (33)
Experimental respiratory distress induced by paraquat (1971) (33)
Combined Effects of Surfactant Substitution and Prolongation of Inspiration Phase in Artificially Ventilated Premature Newborn Rabbits (1982) (32)
Prediction of respiratory distress syndrome by the microbubble stability test on gastric aspirates in newborns of less than 32 weeks’gestation (2003) (32)
Factors influencing morbidity and mortality in infants with severe respiratory distress syndrome treated with single or multiple doses of a natural porcine surfactant. (1992) (30)
Ultrastructure of the alveolar wall in experimental paraquat poisoning. (2009) (30)
Hyaline membrane disease. Effect of surfactant prophylaxis on lung morphology in premature primates. (1978) (30)
Experimental obstructive hydronephrosis in newborn rats. XI. A one-year follow-up study of renal function and morphology. (1989) (29)
Surface adsorption of pulmonary surfactant in relation to bulk-phase concentration and presence of CaCl2. (1983) (29)
Rabbit lungs after long-term exposure to low nickel dust concentration. I. Effects on phospholipid concentration and surfactant activity. (1983) (28)
Pulmonary phospholipids and surface properties of alveolar wash in experimental paraquat poisoning. (1973) (28)
Dextran or Polyethylene Glycol Added to Curosurf for Treatment of Meconium Lung Injury in Rats (2005) (28)
Biophysical and Physiological Properties of Porcine Surfactant Enriched with Polymyxin B (2005) (27)
Surfactant inactivation and surfactant replacement in experimental models of ARDS (1991) (27)
Rabbit lung after inhalation of manganese chloride: a comparison with the effects of chlorides of nickel, cadmium, cobalt, and copper. (1985) (26)
Alveolar macrophage abnormalities in rabbits exposed to low concentrations of trivalent chromium. (1987) (26)
The role of the low-molecular weight (less than or equal to 15,000 daltons) apoproteins of pulmonary surfactant. (1986) (25)
[Lung biopsy in congenital heart disease]. (1971) (25)
Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits. (1994) (25)
Synthetic Surfactant Protein Analogues (1998) (24)
Respiratory failure in mice caused by a hybridoma making antibodies to the 15 kDa surfactant apoprotein (1988) (24)
Correlations between physical and physiological properties of various preparations of lung surfactant. (1986) (24)
Combined effects of high‐frequency ventilation and surfactant treatment in experimental meconium aspiration syndrome (1999) (23)
Nodular accumulation of type II cells and inflammatory lesions caused by inhalation of low cobalt concentrations. (1987) (23)
The evolution of neonatal respiratory distress syndrome into chronic lung disease. (1989) (23)
Corticosteroids and surfactant for prevention of neonatal RDS. (1993) (23)
Surfactant inactivation and surfactant therapy in acute respiratory distress syndrome (ARDS). (1998) (22)
Isoxsuprine infusion to the pregnant rabbit and its effect on fetal lung surfactant. (1979) (22)
Surfactant Treatment and Ventilation by High Frequency Oscillation in Premature Newborn Rabbits: Effect on Survival, Lung Aeration, and Bronchiolar Epithelial Lesions (1985) (22)
Pathophysiology of neonatal lung injury induced by monoclonal antibody to surfactant protein B. (1997) (21)
Effect of surfactant on nitroblue tetrazolium reduction of polymorphonuclear leucocytes stimulated with type la group B streptococci (1995) (21)
A 2-year follow up of babies enrolled in a European multicentre trial of porcine surfactant replacement for severe neonatal respiratory distress syndrome (1992) (20)
Automated techniques for the study of lung alveolar stereological parameters with the IBAS image analyser on optical microscopy sections (1983) (20)
Assessment of surfactant function (1998) (19)
Modified Protocols for Surfactant Therapy in Experimental Meconium Aspiration Syndrome (2003) (19)
Comparison of rapid bolus instillation with simplified slow administration of surfactant in lung lavaged rats (1998) (19)
Pulmonary epithelial permeability. An animal study of inverse ratio ventilation and conventional mechanical ventilation. (1996) (19)
Exogenous porcine surfactant (Curosurf) is inactivated by monoclonal antibody to the surfactant‐associated hydrophobic protein SP‐B (1992) (19)
Pathology of neonatal surfactant deficiency. (1987) (18)
Aerosolized surfactant in lung‐lavaged adult rats: factors influencing the therapeutic response (2000) (18)
Alveolar-to-vascular leakage of surfactant protein A in ventilated immature newborn rabbits. (1995) (18)
Lung protein leakage in respiratory failure induced by a hybridoma making monoclonal antibody to the hydrophobic surfactant-associated polypeptide SP-B. (1992) (18)
Inhibition of exogenous surfactant in ventilated immature newborn rabbits. (1989) (17)
Partial ureteric obstruction in weanling rats. I. Long-term effects on the renal morphology. (1985) (17)
Scanning electron microscopy of epithelial lesions induced by artificial ventilation of the immature neonatal lung; the prophylactic effect of surfactant replacement (1986) (17)
Toxicology of nickel. (1984) (17)
Lung lesions after experimental combined exposure to nickel and trivalent chromium. (1989) (17)
LUNG EXPANSION and THE FORMATION OF THE ALVEOLAR LINING LAYER IN THE FULLTERM NEWBORN RABBIT (1975) (16)
Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment. (1999) (16)
Bubbles and computer-aided image analysis for evaluation of surfactant inhibition. (1992) (15)
Computerized image analysis of bubbles in gastric aspirate for prediction of respiratory distress syndrome (2001) (15)
Influence of Lung Surfactant Phospholipids on Neutrophilic Granulocytes and Blood Monocytes1 (1984) (15)
New targets for surfactant replacement therapy: experimental and clinical aspects. (1996) (15)
Endotracheal administration of surfactant in very low birth weight infants with respiratory distress syndrome. (1987) (14)
Trophoblastic and subtrophoblastic mineral salt deposition in hydramnios. (2009) (14)
Computerized image analysis of lung expansion patterns in surfactant treated immature newborn rabbits. (1999) (13)
Rabbit lung after inhalation of lithium chloride (1988) (13)
Bronchiolar epithelial lesions in spontaneously breathing premature newborn rabbits. (1985) (13)
Background to neonatal respiratory distress syndrome and treatment with exogenous surfactant. (1989) (13)
Mitigation of endotoxin-induced acute lung injury in ventilated rabbits by surfactant and inhaled nitric oxide (2000) (13)
Morphology and function of blood monocytes after incubation with lung surfactant. (1987) (13)
21. PARAQUAT‐INDUCED DERANGEMENT OF PULMONARY SURFACTANT IN THE RAT (1970) (13)
Immunochemical and immunohistochemical evaluation of lung permeability in ventilated newborn rabbits. (1990) (13)
Current and counter-current theories on lung surfactant. (1976) (13)
Postnatal formation and obliteration of arterial anastomoses in the human lung. A microangiographic and histologic study. (1969) (12)
Lung surfactant for replacement therapy. (1983) (12)
Hemodynamics and Tissue Blood Flow after Porcine Surfactant Replacement in Surfactant-Depleted Newborn Piglets (1996) (12)
Raised plasma hypoxanthine levels as a prognostic sign in preterm babies with respiratory distress syndrome treated with natural surfactant (1992) (12)
Influence of modified natural and synthetic surfactant preparations on bacterial killing by polymorphonuclear leucocytes. (2004) (12)
Passive expiratory flow-volume recordings in immature newborn rabbits. Effect of surfactant replacement on the time constant of the respiratory system. (1990) (12)
Lipid Peroxidation of Lung Surfactant in Experimental Neonatal Group B Streptococcal Pneumonia (2003) (11)
Artificial surfactants based on analogues of SP-B and SP-C. (2001) (11)
Lung morphology after late fetal tracheal ligation in rats. (2006) (10)
Idiopathic pulmonary hypertension in infancy and childhood. Microangiographic and histological observations in five cases. (2009) (10)
A case of meningioma with extracranial metastases. (2009) (10)
Intratracheal albumin reduces interleukin-8 in tracheobronchial aspirates in piglets after meconium aspiration (2004) (10)
Surfactant replacement in neonatal and adult respiratory distress syndrome. (1984) (10)
Lung Function and Bacterial Proliferation in Experimental Neonatal Pneumonia in Ventilated Rabbits Exposed to Monoclonal Antibody to Surfactant Protein A (1998) (10)
Concentration Dependence of a Poly-Leucine Surfactant Protein C Analogue on in vitro and in vivo Surfactant Activity (2007) (10)
Abnormalities of the costochondral junction in cases of perinatal death, with special reference to hyaline membrane disease. (2009) (10)
Direct and Phagocyte-mediated Lipid Peroxidation of Lung Surfactant by Group B Streptococci (2000) (10)
Influence of Partial Liquid Ventilation on Bacterial Growth and Alveolar Expansion in Newborn Rabbits with Group B-Streptococcal Pneumonia (2003) (10)
Lung compliance and alveolar expansion in the artificially ventilated premature newborn rabbit after maternal treatment with ambroxol. (1981) (10)
Effect of aminophylline on lung maturation in preterm rabbit fetuses. (1986) (10)
The normal intrapulmonary arterial pattern in infancy and early childhood. A micro-angiographic and histological study. (1967) (10)
Surfactant treatment in experimental hyaline membrane disease. (1981) (9)
Quantitative evaluation of neonatal lung expansion with automated image analysis. (1986) (9)
Therapeutic effects of exogenous surfactant enriched with dextran in newborn rabbits with respiratory failure induced by airway instillation of albumin. (2008) (9)
Paraquat poisoning as an experimental model of the idiopathic respiratory distress syndrome. (1973) (8)
Effect of amiloride and surfactant on lung liquid clearance in newborn rabbits. (1992) (8)
A lung recruitment maneuver immediately before rescue surfactant therapy does not affect the lung mechanical response in immature lambs with respiratory distress syndrome (2003) (8)
Reversal of meconium inhibition of pulmonary surfactant by ferric chloride, copper chloride, and acetic acid. (2000) (8)
Human tartrate nephropathy. Report of a fatal case. (2009) (8)
Vascular to Alveolar Leak of Iron Dextran (120 kD) in the Immature Ventilated Rabbit Lung (1989) (8)
Prolonged ventilation of the premature newborn rabbit after treatment with natural or apoprotein-based artificial surfactant (1988) (8)
Synthetic protein analogues in artificial surfactants (1996) (8)
PULMONARY HYALINE MEMBRANES OF THE NEWBORN. THE STRUCTURE OF THE MEMBRANES AT VARYING POSTNATAL AGE. (1964) (8)
Respiratory Distress Syndrome in Newborns of Less Than 30 Weeks' Gestation Nasal Continuous Positive Airway Pressure and Early Surfactant Therapy for (2010) (8)
Pulmonary surfactant from healthy Belgian White and Blue and Holstein Friesian calves: biochemical and biophysical comparison. (2003) (8)
Renal recovery after release of experimental neonatal ureteric obstruction. (1987) (8)
Effects of experimental obstructive hydronephrosis on the immature nephrons in newborn rats. (1989) (8)
Neonatal respiratory distress syndrome and surfactant therapy; a brief review. (1989) (7)
Surfactant Replacement in Experimental Respiratory Distress Syndrome Induced by Lung Lavage1 (1984) (7)
Update on Surf actant Therapy (1995) (7)
Automated image analysis of alveolar expansion patterns in immature newborn rabbits treated with natural or artificial surfactant. (1987) (7)
Basic morphology of the pulmonary defence system. (1980) (7)
LUNG INJURY CAUSED BY NEONATAL RESUSCITATION OF IMMATURE LAMBS - RELATION TO VOLUME OF LUNG INFLATIONS. † 1942 (1996) (7)
Replacement therapy with porcine natural surfactant--current status and future challenges. Report from the 8th International Workshop on Surfactant Replacement, Oslo, May 20-22, 1993. (1993) (7)
Pulmonary clearance of 99m Tc‐DTPA in experimental surfactant dysfunction treated with surfactant instillation (1997) (7)
Early versus late surfactant replacement therapy in severe respiratory distress syndrome (2007) (7)
Surfactant Replacement Therapy from 1986 to 2006: A 20-Year Success Story (2006) (7)
Pharmacological stimulation of surfactant secretion and surfactant replacement. (1985) (7)
Effect of surfactant and specific antibody on bacterial proliferation and lung function in experimental pneumococcal pneumonia. (2001) (6)
Syringes with rubber-coated plungers and inactivation of surfactant (2003) (6)
Interaction of pulmonary surfactant and alveolar macrophages in the non-specific defence system of the lung. (1980) (6)
Quantitative determination of pulmonary surfactant with pulsating bubble. (1972) (6)
Long-term cycling of surfactant films in Wilhelmy balance. (1996) (6)
The alveolar lining layer in experimental paraquat poisoning. (2009) (6)
Atypical Roentgen Appearances of the Lung in Hyaline Membrane Disease of the Newborn (1970) (6)
Review of experimental hyaline membrane disease. (1981) (6)
[Beneficial effect of surfactant treatment of IRDS]. (1984) (5)
Artificial Surfactants Based on Analogues of SP‐B and SP‐C (2002) (5)
Lung gas volumes and expiratory time constant in immature newborn rabbits treated with natural or synthetic surfactant or detergents. (1994) (5)
The effect of natural porcine surfactant (Curosurf) on the phagocytosis-associated functions of human neutrophils (1991) (5)
Prospects for a new synthetic surfactant. (2000) (5)
Surfactant as an immunogen: implications for therapy of respiratory distress syndrome (1992) (5)
Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SPC (2005) (5)
Lung expansion in premature newborn rabbits treated with emulsified synthetic surfactant; principles for experimental evaluation of synthetic substitutes for pulmonary surfactant. (1984) (5)
Overview of surfactant replacement therapy (1985) (4)
26 Phagocytic functions and TNF secretion of huaan aonocytes exposed to natural porcine surfactant (Curosurf) (1990) (4)
Surfactant substitution; experimental models and clinical applications (2007) (4)
28 RANDOMIZED EUROPEAN MULTICENTER TRIAL OF SURFACTANT REPLACEMENT IN NEONATAL RESPIRATORY DISTRESS SYNDROME (RDS): SINGLE VERSUS MULTIPLE DOSES OF CUROSURF (1990) (4)
The use of exogenous surfactant to treat patients with acute high-permeability lung edema. (1989) (4)
Preceding surfactant treatment does not protect against lung volutrauma at birth † 1518 (1997) (4)
The origin in neonatal lung injury. (1991) (4)
Surface forces in respiratory bronchioles during a first breath-model experiment and some theoretical considerations. (1976) (4)
Artificial Surfactants Based on Different Hydrophobic Low-Molecular-Weight Proteins (1988) (4)
Effect of supplementary surfactant on in vivo lung mechanics in the premature rabbit neonate (1981) (4)
[Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life]. (1990) (4)
Lung Aeration in the Fullterm Newborn Rabbit (1974) (4)
Inactivation of pulmonary surfactant by silicone oil in vitro and in ventilated immature rabbits (2009) (3)
Ethamsylate and lung permeability in ventilated immature newborn rabbits. (1994) (3)
The dilemmas of surfactant replacement. (1991) (3)
Intracerebral haemorrhages in surfactant treated neonates with severe respiratory distress syndrome: age at diagnosis, severity and risk factors (1994) (3)
European multicenter trials of curosurf for treatment of neonatal respiratory distress syndrome (2007) (3)
Modification of pulmonary surfactant in the rat by vitamin A, pilocarpine and paraquat. (1970) (3)
Hydrophobic Surfactant Proteins SP-B and SP-C: Special Analytical Problems (1991) (3)
[The effect of intermittent hydrogen chloride exposure on the lung function of the guinea pig]. (1982) (3)
Arterial Bronchopulmonary Anastomoses (1969) (2)
Cerebral blood flow velocity changes after rapid administration of surfactant. (1992) (2)
Author and Subject Index (2004) (2)
Pulmonary surfactant: emerging protein analogues. (1999) (2)
Effect of tracheal deposition of surfactant on air expansion of lungs--study on premature rabbit fetuses. (1973) (2)
Effects on the rabbit lung of combined exposure to nickel and trivalent chromium (1988) (2)
Expansion patterns in the premature rabbit after tracheal deposition of surfactant. (1971) (2)
Treatment of the Premature Rabbit Neonate with Supplementary Surfactant (1981) (2)
Choosing the Surfactant for Replacement Therapy (1984) (2)
The association between trabecular rarefaction in the costochondral junction and the idiopathic respiratory distress syndrome. (1970) (2)
Treatment of experimental Cryptococcus neoformans infection in newborn rabbits by airway instillation of specific antibody and surfactant (2000) (2)
Roentgenmicrography of the Human Neonatal Lung in Infantile Lobar Emphysema and Cystic Adenomatoid Malformation (1972) (2)
HYALINE MEMBRANES IN BRONCHIAL‐ARTERY SUPPLIED AREAS OF THE HUMAN NEONATAL LUNG: A Microangiographical and Histological Study (1970) (2)
[Treatment of severe respiratory distress syndrome in the premature infant with natural surfactant]. (1988) (2)
162 Acute Blood Pressure Effects of Surfactant Replacement in Newborn Piglets (1994) (2)
[Effect of natural porcine surfactant (Curosurf) on the function of neutrophilic granulocytes]. (1990) (2)
Paraquat poisoning as an experimental model of idiopathic respiratory distress. (1970) (2)
The European Multicenter Trial of Surfactant Replacement in Neonatal Respiratory Distress Syndrome (1988) (2)
Lung Trauma From Five Moderately Large Manual Inflations Immediately After Surfactant Instillation in Newborn Immature Lambs † 1678 (1998) (2)
Ultrastructural abnormalities in young patients with recurrent respiratory infections. (1982) (1)
Surfactant (SF) Treatment on Congenital Diaphragmatic Hernia (CDH). Retrospective Study (1999) (1)
Better Neonatal Outcomes : Oxygen , Surfactant and Drug Delivery (2013) (1)
SHORT-TERM CLINICAL RESPONSE AND FOLLOW-UP IN 164 BABIES TREATED WITH PORCINE SURFACTANT (CUROSURF) FOR SEVERE NEONATAL RESPIRATORY DISTRESS SYNDROME (RDS) (1989) (1)
The Newborn at High Risk of Brain Damage (2001) (1)
Effects of antenatal hydrocortisone on tidal volumes in spontaneously breathing preterm newborn rabbits. Possible mediation by adrenal catecholamines. (1988) (1)
[Effect of 2 different dosages of a porcine surfactant on pulmonary gas exchange of premature infants with severe respiratory distress syndrome]. (1993) (1)
Scanning Electron Microscopic Studies of Expansion Patterns and Epithelial Lesions in Surfactant-Deficient Immature Lungs (1984) (1)
Abstracts from the Meeting ‘Neonatal Therapy: An Update’ (1985) (1)
The neonatal intrapulmonary arterial pattern in transposition of the great arteries (1968) (1)
The incidence and structure of bronchopulmonary arteries in infancy and early childhood. (1969) (1)
Transcutaneous PO2 and PCO2 during surfactant therapy in newborn infants with idiopathic respiratory distress syndrome. (1987) (1)
Growth in height and osseous maturation in response to human growth hormone therapy (2006) (1)
Subject Index Vol. 77, Suppl. 1, 2000 (2000) (1)
Update on surfactant therapy. Report from the 9th International Workshop on Surfactant Replacement, Jerusalem, May 22-25, 1994. (1995) (1)
Ultrastructure of the alveolar epithelium and the alveolar lining layer in paraquat-induced experimental respiratory distress. (1971) (1)
Preface (2008) (1)
Biophysical Aspects of the Surfactant System in Relation to Neonatal Lung Function (1996) (1)
Pulmonary Surfactant (1999) (1)
Antibody to Surfadant Protein A Increases Sensitivi9' of Pulmonary Surfactant to Inadivatlon by Fibrinogen in vivo (1996) (1)
Pharmaceutical compositions having improved surface properties containing a lung surfactant and a polymyxin (2002) (0)
Paraquat-induced respiratory distress in the rat (film). (1970) (0)
Title Pages / Contents (1999) (0)
Preface (2004) (0)
Preface (2003) (0)
New Challenges in Surfactant Research: 15th International Workshop on Surfactant Replacement, Kos, June 2000: Proceedings (2000) (0)
Contents, Vol. 65, 1994 (1994) (0)
Densitometric Evaluation of Lung Aeration in Chest Films (1976) (0)
Improved Lung‐Thorax Compliance in the Premature Rabbit Neonate After Treatment With Dibuturyladenosine‐3′:5′‐Cyclic Monophosphate (1984) (0)
Lung biopsy diagnosis of secondary vascular lesions in congenital heart disease. (1971) (0)
Subject Index Vol. 93, 2008 (2008) (0)
15 CEREBRAL- (CBFV) AND AOBTIC BLOOD PLOW VELOCTIY (AoBFV) IN PRETEM INFANTS DURING AND AFTER SURFACTANT (SF) TREAMENT (1990) (0)
Neonatology. Preface. (2008) (0)
Iron abolishes inhibitory effects of meconium on surfactant (1999) (0)
Surfactant and Nasal-Cpap Before 30 Weeks of Gestation (1997) (0)
Automated image analysis of alveolar expansion patterns in immature newborn rabbits treated with natural or (2007) (0)
Contents Vol. 85, 2004 (2004) (0)
[Surfactant substitution in severe respiratory distress syndrome in premature infants weighing less than 1,000 g]. (1990) (0)
The effect of cytidine diphosphate choline on in vivo lung mechanics in premature newborn rabbits. (1980) (0)
100 IMMUNE RESPONSE AFTER HETEROLOGOUS SURFACTANT TREATMENT OF NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME (RDS) (1990) (0)
More about Surfactant and Prevention of Pain and Chronic Lung Disease (2008) (0)
Author Index, Extended Abstracts (1996) (0)
[Newly discovered association between lung disease and surfactant proteins]. (2002) (0)
Process for the preparation of surface-active substances of animal lungs (1988) (0)
Contents, Vol. 16, 1970 (1970) (0)
Experiences with Curosurf in Europe (1991) (0)
23rd International Workshop on Surfactant Replacement, Brugge, June 5–7, 2008 (2008) (0)
Pharmaceutical compositions comprising the lung surfactant and a polymyxin and have improved surface tension lowering properties (2002) (0)
22nd International Workshop on Surfactant Replacement, Ancona, June 7–9, 2007 (2006) (0)
Clinical Management and Experimental Models of Surfactant-Related Lung Disease: 17th International Workshop on Surfactant Replacement, Cagliari, May 2002: Proceedings (2002) (0)
New avenues in surfactant research. (2001) (0)
Contents, Vol. 67, Supplement 1, 1995 (1995) (0)
Preface (1999) (0)
Hydrophobic Proteins and Their Analogues in Pulmonary Surfactant (1996) (0)
148 ACTIVATION OF THE PLASMA KALLIKREIN-KININ SYSTEM IN RDS IS NOT INFLUENCED BY TREATMENT WITH NATURAL SURFACTANT (1990) (0)
THE JOY AND BENEFITS OF SURFACTANT REPLACEMENT SNAPSHOTS FROM THE EVOLUTION OF A NEW PRINCIPLE FOR TREATMENT OF NEONATAL RESPIRATORY DISTRESS SYNDROME (1995) (0)
Surfactant replacement in severe RDS: effects of perinatal acidosis on therapeutic response (1991) (0)
[Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome]. (1994) (0)
WASHING OUT OF HYPOXANTHINE (HX) IN PRETERM BABIES WITH RDS TREATED WITH NATURAL SURFACTANT (CUROSURF) (1989) (0)
New lipid mixtures of synthetic surfactants (2004) (0)
Preface (1998) (0)
11th Workshop on Surfactant Replacement (1996) (0)
Perinatal pathology of costochondral junction in relation to pulmonary hyaline membranes. (1970) (0)
[Treatment of preterm neonates with severe respiratory distress syndrome using exogenous natural surfactants of porcine origin]. (1992) (0)
Subject Index Vol. 85, 2004 (2004) (0)
Contents Vol. 91, 2007 (2006) (0)
Measurement of extravascula lung water - methods and clinical implications. Discussion (1991) (0)
Preface (2000) (0)
Preface (2001) (0)
Preface (2005) (0)
Experimental and Clinical Aspects of Surfactant Replacement: European Workshop on Surfactant Replacement, Hviz, Hungary, May 1991: Selected papers (1992) (0)
The pproteins oof tthe ssurfactant ssystem (1994) (0)
Further Advances in Surfactant Replacement: 16th International Workshop on Surfactant Replacement, Edinburgh, June 2001: Proceedings (2001) (0)
Proceedings of the 20th International Workshop on Surfactant Replacement, Belfast, June 2–5, 2005 (2005) (0)
Surfactant Therapy: Present and Future Perspectives. Proceedings of the 21st International Workshop on Surfactant Replacement, Oslo, June 1–4, 2006 (2006) (0)
Proceedings of the 17th International Workshop on Surfactant Replacement, Cagliari, May 24-26, 2002 - Preface (2002) (0)
Contents, Vol. 61, Supplement 1, 1992 (1992) (0)
Update on neonatal respiratory disorders and surfactant : proceedings of the 14th International Workshop on Surfactant Replacement, Skagen, June 23-25, 1999 (1999) (0)
Contents, Vol. 61, Supplement 1, 1992 (1992) (0)
Porcine Derived Lung Surfactant, 10 Years of Research: 10th Workshop on Surfactant Replacement, Versailles, May 1995: Proceedings (1995) (0)
Animal Models of Surfactant Dysfunction (1995) (0)
Irish perinatal society (1993) (0)
Surfactant Treatment for Inflammatory Lung Disease (2005) (0)
Contents, Vol. 29, 1976 (1976) (0)
Artificial peptides having surface activity and their use for the production of artificial surfactants (2000) (0)
IMMUNOHISTOCHEMICAL STUDY OF THE DISTRIBUTION OF EXOGENOUS SURFACTANT IN THE LUNGS OF SURFACTANT DEFICIENT RABBITS USING A MONOCLONAL ANTIBODY (1987) (0)
Subject Index Vol. 91, 2007 (2006) (0)
Contents Vol. 93, 2008 (2008) (0)
Surfactant Replacement: Theory and Practice (1987) (0)
Subject Index Vol. 87, 2005 (2005) (0)
EXOSURF VERSUS CUROSURF; COMPARISON OF SURFACE PROPERTIES, RESISTANCE TO INHIBITION, AND PHYSIOLOGICAL EFFECTS IN PRETERM RABBITS (1992) (0)
New Perspectives of Surfactant Research: 12th International Workshop on Surfactant Replacement, Stockholm, May 1997: Proceedings (1997) (0)
Comparison ofsurface properties and physiological effects ofa synthetic anda natural surfactant inpretermrabbits (2017) (0)
Surfactant replacement in the management of the neonatal respiratory distress syndrome. (1987) (0)
The intrapulmonary arterial pattern in infants with transposition of the great arteries associated with interventricular septum defect (1968) (0)
14th Annual International Workshop on Surfactant Replacement, Skagen, Denmark, June 23-25, 1999: Preface (1999) (0)
[Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome]. (1994) (0)
Pressure-Controlled Inverse Ratio Ventilation-To the Editor (1997) (0)
PULMONARY LIPID DEPOSITS AFTER SURFACTANT SUBSTITUTION FOR NEONATAL RESPIRATORY DISTRESS SYNDROME (RDS) (1989) (0)
Update on Neonatal Respiratory Disorders and Surfactant: 14th International Workshop on Surfactant Replacement, Skagen, June 1999: Proceedings (1999) (0)
Surfactant Deficiency and Surfactant Inactivation in Experimental Neonatal Respiratory Distress Syndrome (1994) (0)
Preface (2007) (0)
99 VARIATION IN INTRATISSUE Po2 IN RELATION TO SURFACTANT REPLACEMENT IN SURFACTANT DEPLETED NEWBORN PIGS (1994) (0)
Contents Vol. 87, 2005 (2005) (0)
Postnatal prevention and treatment of surfactant deficiency. (1989) (0)
Developmental and Clinical Aspects of Surfactant-Related Neonatal Lung Disease (2003) (0)

This paper list is powered by the following services:

Other Resources About Bengt Robertson

en.wikipedia.org

What Schools Are Affiliated With Bengt Robertson?

Bengt Robertson is affiliated with the following schools:

Bengt Robertson's Academic­Influence.com Rankings